Floatz logo

Perampanel

Idiopathic Generalized Epilepsy

Eisai LimitedSmall moleculeUnknownDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Idiopathic Generalized Epilepsy cohort.

Asset / SponsorPhaseRating
Valproic Acid
Mazandaran University of Medical Sciences
Phase 4BB
Cenobamate
SK Life Science, Inc.
Phase 3BB
Apomorphinum
Institut National de la Santé Et de la Recherche Médicale, France
N/AD

Same molecule, other indications

Perampanel is also rated in:

epilepsyActive
BB
Indicative · Phase 4
71 / 100
View asset →
neuralgiaDormant
BB
Indicative · Phase 2/3
66 / 100
View asset →
grade II gliomaDormant
B
Indicative · Phase 4
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →